Craig-Hallum Downgrades Haemonetics (HAE) to Hold
Craig-Hallum downgraded Haemonetics (NYSE: HAE) from Buy to Hold.
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
